Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06525623 · ClinicalTrials.gov registry record · NA
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
A NA study of Acute Kidney Injury and Cirrhosis, Liver, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06525623 is a NA study of Acute Kidney Injury and Cirrhosis, Liver that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06525623, a NA study of Acute Kidney Injury and Cirrhosis, Liver, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional study is to evaluate two strategies for how to provide intravenous (IV) fluids for treating patients with acute kidney injury (AKI) in cirrhosis. The main question it aims to answer is: what is the safety, efficacy, and feasibility of providing a recommendation to use a Volume Assessment Guidance Algorithm (VAGA) or give standard of care doses of IV albumin? Patients will be randomly assigned where their treating teams will receive a VAGA-based recommendation or a standard of care IV albumin recommendation.
Conditions Studied
Interventions
- OTHER Recommendation: No Further Resuscitation
- OTHER Recommendation: Resuscitation with Crystalloid
- OTHER Recommendation: Resuscitation with Colloid
- OTHER Recommendation: Standard of Care IV Albumin
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-09-12 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06525623
The ClinicalTrials.gov registry entry for NCT06525623 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (98% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 4 interventions - of which Recommendation: No Further Resuscitation is the first listed.
NCT06525623 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06525623 about?
NCT06525623 is a clinical study titled "Initial Resuscitation for Acute Kidney Injury in Cirrhosis". The goal of this interventional study is to evaluate two strategies for how to provide intravenous (IV) fluids for treating patients with acute kidney injury (AKI) in cirrhosis. The main question it aims to answer is: what is the safety, efficacy, and feasibility of providing a recommendation to use...
What is the current status of trial NCT06525623?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-12. Estimated completion is 2027-05-01.
What conditions does trial NCT06525623 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Cirrhosis, Liver, Hepatorenal Syndrome.
What interventions are being tested in trial NCT06525623?
The interventions under investigation include: Recommendation: No Further Resuscitation (OTHER), Recommendation: Resuscitation with Crystalloid (OTHER), Recommendation: Resuscitation with Colloid (OTHER), Recommendation: Standard of Care IV Albumin (OTHER).
Who is sponsoring clinical trial NCT06525623?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06525623 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
-
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
RECRUITING · NA
-
CTSN Embolic Protection Trial
RECRUITING · NA
-
A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention
RECRUITING · NA
-
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
RECRUITING · NA
-
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.